Results 151 to 160 of about 920 (164)

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Lancet, The, 2021
Jong-Mu Sun, Manish A Shah, Toshihiko Doi   +2 more
exaly  

First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial

Nature Medicine, 2023
Bo Zhang, Jing Huang
exaly  

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Signal Transduction and Targeted Therapy, 2023
Bin-Yan Zhong, Zhi-Cheng Jin
exaly  

1800 Enhancing Detection: The Role of CINtec® PLUS in Diagnosing High-Grade Squamous Lesions in Anal Cytology

Laboratory Investigation
Temitope Kehinde, Andrea Buitrago, Roberto Ruiz-Cordero, Manuel Lora Gonzalez, Carmen Gomez-Fernandez, Jaylou Velez Torres, Merce Jorda, Youley Tjendra, Yiqin Zuo, Monica Garcia-Buitrago   +9 more
openaire   +1 more source

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Lancet, The, 2019
Stefan Kasper, Hans-Georg Kopp, Georg Martin Haag   +2 more
exaly  

The use of the elevated plus maze as an assay of anxiety-related behavior in rodents

Nature Protocols, 2007
Alicia A Walf, Cheryl A Frye
exaly  

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Lancet, The, 2019
Luis Paz-Ares, Katsuyuki Hotta, Oleksandr Voitko   +2 more
exaly  

Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine

Cell, 2010
Ken Cadwell, Ta-Chiang Liu, Ramnik J Xavier   +2 more
exaly  

Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

Nature Medicine, 2018
Rishu Agarwal, Yih-Chih Chan, Constantine S Tam   +2 more
exaly  

Ovarian function suppression is beneficial in some premenopausal women with early breast cancer

Ca-A Cancer Journal for Clinicians, 2016
exaly